Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 7/20 | 1.00 |
| ▸ | MAPT | P10636 | 6/20 | 0.74 |
| ▸ | APP | P05067 | 4/20 | 0.74 |
| ▸ | GSK3B | P49841 | 2/20 | 0.62 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.57 |
| ▸ | TTR | P02766 | 1/20 | 0.57 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.57 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3222937 | 1.00 | BACE1 (1.00) | BACE1MAPTAPPGSK3BALOX5 | |
| SCHEMBL3200533 | 0.92 | BACE1 (0.85) | BACE1MAPTAPPGSK3BALOX5 | |
| SCHEMBL3200543 | 0.92 | BACE1 (0.85) | BACE1MAPTAPPGSK3BALOX5 | |
| SCHEMBL3222958 | 0.87 | BACE1 (0.77) | BACE1MAPTAPPGSK3BALOX5 | |
| SCHEMBL3222975 | 0.87 | BACE1 (0.77) | BACE1MAPTAPPGSK3BALOX5 | |
| SCHEMBL3225272 | 0.86 | MAPT (0.81) | BACE1MAPTAPPGSK3BALOX5 | |
| SCHEMBL3225257 | 0.86 | MAPT (0.81) | BACE1MAPTAPPGSK3BALOX5 | |
| SCHEMBL3222896 | 0.86 | APP (1.00) | BACE1MAPTAPPGSK3BALOX5 | |
| SCHEMBL3222917 | 0.86 | APP (1.00) | BACE1MAPTAPPGSK3BALOX5 | |
| SCHEMBL4685073 | 0.84 | BACE1 (0.73) | BACE1MAPTAPPALOX5PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8962674-B2 | Curcumin derivative | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2015-02-24 | — | — | US | disclosed |
| US-20100048901-A1 | NOVEL CURCUMIN DERIVATIVE | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2010-02-25 | — | — | US | disclosed |
| EP-2123637-A1 | NOVEL CURCUMIN DERIVATIVE | Tokyo Institute of Technology (JP) | 2009-11-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048901-A1 | NOVEL CURCUMIN DERIVATIVE | BACE1, APP, BACE2 | BACE1 1/4885MAPT 8/4885APP 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.